Free Trial

Abbott Laboratories (ABT) SEC Filings & 10K Form

Abbott Laboratories logo
$131.67 +5.06 (+3.99%)
Closing price 03/27/2025 03:59 PM Eastern
Extended Trading
$131.75 +0.08 (+0.06%)
As of 03/27/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Abbott Laboratories SEC Filings

DateFilerForm TypeView
03/07/2025
5:55 PM
Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
5:28 PM
Abbott Laboratories (Subject)
Earnhardt Lisa D (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
4:47 PM
Abbott Laboratories (Subject)
Earnhardt Lisa D (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:54 PM
Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM
Abbott Laboratories (Issuer)
Shroff Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:05 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:33 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:39 PM
Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:44 PM
Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:21 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:27 PM
Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:00 PM
Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
7:40 PM
Abbott Laboratories (Subject)
Shroff Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
7:29 PM
Abbott Laboratories (Issuer)
Shroff Eric (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/03/2025
6:58 PM
Abbott Laboratories (Subject)
Moreland Mary K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
7:08 PM
Abbott Laboratories (Subject)
Morrone Louis H. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
7:18 PM
Abbott Laboratories (Subject)
Wainer Andrea F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
6:52 PM
Abbott Laboratories (Subject)
MCCOY JOHN A. JR. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
5:47 PM
Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:56 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:07 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:17 PM
Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:26 PM
Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:35 PM
Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
4:37 PM
Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
4:46 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
4:51 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
5:52 PM
Abbott Laboratories (Subject)
Ford Robert B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
6:08 PM
Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
6:16 PM
Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
6:33 PM
Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
4:33 PM
Abbott Laboratories (Subject)
ALLEN HUBERT L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2025
4:26 PM
Abbott Laboratories (Subject)
Salvadori Daniel Gesua Sive (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
4:30 PM
Abbott Laboratories (Subject)
ALLEN HUBERT L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
6:13 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
4:26 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2024
4:14 PM
Abbott Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/23/2024
4:10 PM
Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
6:37 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
4:27 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:33 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
New “Trump” currency proposed in DC (Ad)

According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.

When you see what could happen – I think you’ll be excited.
10/01/2024
4:39 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:48 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:24 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
5:20 PM
Abbott Laboratories (Subject)
Ford Robert B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
7:03 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
6:52 PM
Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:02 PM
Abbott Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/18/2024
6:37 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
3:39 PM
Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:30 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
4:35 PM
Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
5:59 PM
Abbott Laboratories (Subject)
Earnhardt Lisa D (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2024
3:02 PM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
5:05 PM
Abbott Laboratories (Issuer)
McKinstry Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
5:11 PM
Abbott Laboratories (Issuer)
O'Grady Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
5:16 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
5:22 PM
Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
5:29 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:54 PM
Abbott Laboratories (Issuer)
Kumbier Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
5:00 PM
Abbott Laboratories (Issuer)
McDew Darren W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:43 PM
Abbott Laboratories (Issuer)
Blount Sally E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:48 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:33 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:38 PM
Abbott Laboratories (Issuer)
Babineaux-Fontenot Claire (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
6:36 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
5:50 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:58 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:32 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:40 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NYSE:ABT) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners